A Splicing Variant of the RON Transcript Induces Constitutive Tyrosine Kinase Activity and an Invasive Phenotype

REFERENCES

• Alberini, C. M., P. Bet, C. Milstein, and R. Sitia. 1990. Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature (London) 347: 485–487.
   PubMedGoogle Scholar
• Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowski, and R. N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47: 3239–3245.
   PubMed Web of Science ®Google Scholar
• Andreadis, A., M. E. Gallengo, and B. Nadal-Ginard. 1987. Generation of protein isoform diversity by alternative splicing: mechanism and biological implications. Annu. Rev. Cell Biol. 3: 207–242.
   PubMedGoogle Scholar
• Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons, New York.
   Google Scholar
• Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by point mutations altering the transmembrane domain of pl85. Cell 45: 649–657.
   PubMed Web of Science ®Google Scholar
• Breitbart, R. E., A. Andreadis, and B. Nadal-Ginard. 1987. Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu. Rev. Biochem. 56: 467–495.
   PubMed Web of Science ®Google Scholar
• Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–159.
   PubMed Web of Science ®Google Scholar
• Comoglio, P. M., and C. Boccaccio. The hgf receptor family: unconventional signal transducers for invasive cell growth. Genes Cells, in press.
   Google Scholar
• Cooper, C. S., M. Park, D. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (London) 311: 29–33.
   PubMed Web of Science ®Google Scholar
• Coulier, F., R. Kumar, M. Ernst, R. Klein, D. Martin Zanca, and M. Barbacid. 1990. Human trk oncogene activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol. Cell. Biol. 10: 4202–4210.
   PubMedGoogle Scholar
• Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, and J. S. Mattick. 1991. “Touchdown” PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19: 4008–4017.
   PubMed Web of Science ®Google Scholar
• Downword, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature (London) 307: 521–527.
   PubMedGoogle Scholar
• Gaudino, G., A. Follenzi, L. Naldini, C. Collesi, M. Santoro, K. A. Gallo, P. J. Godowski, and P. M. Comoglio. 1994. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13: 3524–3532.
   PubMed Web of Science ®Google Scholar
• Giordano, S., M. F. Di Renzo, R. Narsimhan, C. S. Cooper, C. Rosa, and P. M. Comoglio. 1989. Biosynthesis of the protein encoded by the c-met protooncogene. Oncogene 4: 1383–1388.
   PubMed Web of Science ®Google Scholar
• Giordano, S., C. Ponzetto, M. F. Di Renzo, C. S. Cooper, and P. M. Comoglio. 1989. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature (London) 339: 155–156.
   PubMed Web of Science ®Google Scholar
• Huff, J. L., M. A. Jelinek, C. A. Borgman, T. J. Lansing, and T. J. Parsons. 1993. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc. Natl. Acad. Sci. USA 90: 6140–6144.
   PubMed Web of Science ®Google Scholar
• Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15: 3979–3988.
   PubMedGoogle Scholar
• Hurtley, S. M., and A. Helenius. 1989. Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5: 277–307.
   PubMedGoogle Scholar
• Itoh, H., Y. Hattori, H. Sakamoto, H. Ishii, T. Kishi, H. Saski, T. Yoshida, M. Koono, T. Sugimura, and M. Terada. 1994. Preferential alternative splicing in cancer generates a K-sam messanger RNA with higher transforming activity. Cancer Res. 54: 3237–3241.
   PubMedGoogle Scholar
• Klausner, R. D., and R. Sitia. 1990. Protein degradation in the endoplasmic reticulum. Cell 62: 611–614.
   PubMed Web of Science ®Google Scholar
• Kobayashi, H., O. Hidekazu, M. Sugimura, H. Shinohara, T. Fuju, and T. Terao. 1992. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 52: 3610–3614.
   PubMed Web of Science ®Google Scholar
• Lee, C., and K. M. Yamada. 1994. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. J. Biol. Chem. 270: 507–510.
   Google Scholar
• Longati, P., A. Bardelli, C. Ponzetto, L. Naldini, and P. M. Comoglio. 1994. Tyrosines123-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9: 49–57.
   PubMed Web of Science ®Google Scholar
• Martin-Zanca, D., R. Oskam, G. Mitra, T. Copeland, and M. Barbacid. 1989. Molecular and biochemical characterization of the human TRK protooncogene. Mol. Cell. Biol. 9: 24–33.
   PubMed Web of Science ®Google Scholar
• Medico, E., A. Mongiovì, J. Huff, M. A. Jelinek, A. Follenzi, G. Gaudino, J. T. Parsons, and P. M. Comoglio. 1996. The tyrosine kinase receptors ron and sea control “scattering” and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell. 7: 495–504.
   PubMed Web of Science ®Google Scholar
• Mondino, A., S. Giordano, and P. M. Comoglio. 1991. Defective posttrans-lational processing activates the tyrosine kinase encoded by the MET protooncogene (hepatocyte growth factor receptor). Mol. Cell. Biol. 11: 6084–6092.
   PubMedGoogle Scholar
• Neilson, K. M., and R. E. Friesel. 1995. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270: 26037–26040.
   PubMed Web of Science ®Google Scholar
• Nelson, K. K., and M. R. Green. 1988. Splice site selection and ribonucleoprotein complex assembly during in vitro pre-mRNA splicing. Genes Dev. 2: 319–329.
   PubMedGoogle Scholar
• Oda, T., Y. Kanai, K. Yoshiura, Y. Shimoyama, W. Birchmeier, T. Sugimura, and S. Hirohashi. 1994. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA 91: 1858–1862.
   PubMed Web of Science ®Google Scholar
• Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. F. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84: 6379–6383.
   PubMed Web of Science ®Google Scholar
• Pelham, H. R. B., 1989. Control of protein exit from the endoplasmic reticulum. Annu. Rev. Cell Biol. 5: 1–23.
   PubMedGoogle Scholar
• Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, P. Dalla Zonca, S. Giordano, A. Graziani, G. Panayotou, and P. M. Comoglio. 1994. A multifunctional docking site mediates signalling and transformation by hepatocyte growth factor/ scatter factor (HGF/SF) receptor family. Cell 77: 1–20.
   Google Scholar
• Qiu, F., P. Ray, K. Brown, P. E. Barker, S. Jhanwar, F. H. Ruddle, and P. Besmer. 1988. Primary structure of c-kit: relationship with the CSF/PDGF receptor tyrosine kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C-terminus. EMBO J. 7: 1003–1011.
   PubMed Web of Science ®Google Scholar
• Reddy, P., A. Sparvoli, C. Fagioli, G. Fassina, and R. Sitia. 1996. Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig-light chains. EMBO J. 15: 2077–2085.
   PubMedGoogle Scholar
• Rodriguez, G. A., M. A. Naujokas, and M. Park. 1991. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol. 11: 2962–2970.
   PubMedGoogle Scholar
• Ronsin, C., F. Muscatelli, M. G. Mattei, and R. Breathnach. 1993. A novel putative tyrosine kinase of the Met family. Oncogene 8: 1195–1202.
   PubMed Web of Science ®Google Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.
   PubMed Web of Science ®Google Scholar
• Santoro, M., F. Carlomagno, A. Romano, D. P. Bottaro, N. A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M. H. Kraus, and P. P. Di Fiore. 1995. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267: 381–383.
   PubMed Web of Science ®Google Scholar
• Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Müller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14: 7068–7077.
   PubMed Web of Science ®Google Scholar
• Sorokin, A., M. A. Lemmon, A. Ullrich, and J. Schlessinger. 1994. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269: 9752–9759.
   PubMed Web of Science ®Google Scholar
• Takahashi, M., and G. M. Cooper. 1987. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol. Cell. Biol. 7: 1378–1385.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14: 1347–1354.
   PubMed Web of Science ®Google Scholar
• Terranova, V. P., E. S. Hujanen, D. M. Loeb, G. R. Martin, L. Thornburg, and V. Glushko. 1986. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Natl. Acad. Sci. USA 83: 465–469.
   PubMed Web of Science ®Google Scholar
• Terranova, V. P., E. S. Hujanen, and G. R. Martin. 1986. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77: 311–316.
   PubMed Web of Science ®Google Scholar
• Wahl, G., M. Stern, and R. Stark. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxy-methyl-paper and rapid hybridization by using dextran sulfate. Proc. Natl. Acad. Sci. USA 58: 7001–7005.
   Google Scholar
• Watowich, S. S., A. Yoshimura, G. D. Longmore, D. J. Hilton, Y. Yoshimura, and H. F. Lodish. 1992. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 89: 2140–2144.
   PubMed Web of Science ®Google Scholar
• Woolford, J. W., A. McAuliffe, and L. R. Rohrschneider. 1988. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 55: 965–977.
   PubMed Web of Science ®Google Scholar
• Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13: 3660–3674.
   PubMedGoogle Scholar